CAR T cell therapy has revolutionized the treatment of many blood cancers, but has shown little success against solid tumors, ...

Since scientists first discovered that human immune cells could be modified to become cancer-fighting agents, they've been trying to engineer a cell that's effective against solid tumors, which ...

Each year, approximately 36,000 people are diagnosed with the disease in the United States, according to the American Cancer ...

Organ transplant recipients (OTRs) treated with azathioprine (AZA) face an increased risk for nonmelanoma skin cancer (NMSC), particularly squamous cell carcinoma (SCC), according to an updated ...

Scientists have discovered why ovarian cancer spreads so rapidly through the abdomen. Cancer cells enlist normally protective abdominal cells, forming mixed groups that work together to invade new ...

Scientists have uncovered a surprising way tumors turn the immune system to their advantage. Researchers at the University of Geneva found that neutrophils—normally frontline defenders against ...

Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells ...

EPFL researchers have developed preclinical models for invasive lobular carcinoma and trialed a new drug. It slows tumor growth effectively by targeting specific features of the disease and opening ...

The principle behind cancer-spotting blood tests is relatively simple. Some, like Galleri, analyse DNA fragments shed by ...